{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:27Z","timestamp":1790791287911,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ck0106251"],"award-info":[{"award-number":["17ck0106251"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K09921"],"award-info":[{"award-number":["17K09921"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.cancergen.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T02:57:54Z","timestamp":1520477874000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Mutation analysis of therapy-related myeloid neoplasms"],"prefix":"10.1016","volume":"222-223","author":[{"given":"Takahiro","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-0390","authenticated-orcid":false,"given":"Yoshiya","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.cancergen.2018.02.006_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cancergen.2018.02.006_bib0002","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.cancergen.2018.02.006_bib0003","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study","volume":"33","author":"Granfeldt Ostgard","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cancergen.2018.02.006_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.23908","article-title":"Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry","volume":"90","author":"Hulegardh","year":"2015","journal-title":"Am J Hematol"},{"issue":"15","key":"10.1016\/j.cancergen.2018.02.006_bib0005","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","article-title":"Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975\u20132008","volume":"121","author":"Morton","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cancergen.2018.02.006_bib0006","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/ijerph9062075","article-title":"Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents","volume":"9","author":"Cowell","year":"2012","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.cancergen.2018.02.006_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/asheducation.V2016.1.24.088333","article-title":"Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?","volume":"2016","author":"Heuser","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.cancergen.2018.02.006_bib0008","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2012.076729","article-title":"Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia","volume":"98","author":"Shih","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cancergen.2018.02.006_bib0009","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk Res"},{"issue":"7540","key":"10.1016\/j.cancergen.2018.02.006_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.cancergen.2018.02.006_bib0011","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.cancergen.2018.02.006_bib0012","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cancergen.2018.02.006_bib0013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.cancergen.2018.02.006_bib0014","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.cancergen.2018.02.006_bib0015","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/1042819021000040206","article-title":"Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR","volume":"43","author":"Osumi","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.cancergen.2018.02.006_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2012.225","article-title":"Role and potential for therapeutic targeting of MYB in leukemia","volume":"27","author":"Pattabiraman","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cancergen.2018.02.006_bib0017","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0092-8674(91)90099-K","article-title":"A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis","volume":"65","author":"Mucenski","year":"1991","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cancergen.2018.02.006_bib0018","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2018.02.006_bib0019","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2005-12-5014","article-title":"c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells","volume":"108","author":"Hess","year":"2006","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cancergen.2018.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev"},{"issue":"9","key":"10.1016\/j.cancergen.2018.02.006_bib0021","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.leu.2401113","article-title":"Truncated c-Myb expression in the human leukemia cell line TK-6","volume":"12","author":"Tomita","year":"1998","journal-title":"Leukemia"},{"issue":"7360","key":"10.1016\/j.cancergen.2018.02.006_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cancergen.2018.02.006_bib0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:50Z","timestamp":1761896510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218300048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":23,"alternative-id":["S2210776218300048"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.02.006","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation analysis of therapy-related myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}